Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837681 · ClinicalTrials.gov registry record
Pulmonary Complications of Hematopoietic Stem Cell Transplantation
A clinical trial of Lung Disease, sponsored by Karen Wood.
- Completed
- Registry status
- 350
- Enrollment target
- 1
- Study location
NCT00837681 is a study of Lung Disease that has completed, run by Karen Wood. The registered enrollment target is 350 participants, below the 987-participant average among 3 other Lung Disease trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00837681, a study of Lung Disease, has completed, sponsored by Karen Wood.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine risk factors associated with the development of lung disease after hematopoietic stem cell transplantation. Depending on the results and findings of this study, it may be possible to predict who is at higher risk of serious complications and ultimately develop therapies to prevent or treat this lung disease.
Conditions Studied
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2005-10 |
| Est. Completion | 2016-07-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00837681
The ClinicalTrials.gov registry entry for NCT00837681 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 987-participant average among 3 other Lung Disease trials with a reported enrollment target (65% lower). The listed sponsor is Karen Wood, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00837681 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00837681 about?
NCT00837681 is a clinical study titled "Pulmonary Complications of Hematopoietic Stem Cell Transplantation". The purpose of this study is to determine risk factors associated with the development of lung disease after hematopoietic stem cell transplantation. Depending on the results and findings of this study, it may be possible to predict who is at higher risk of serious complications and ultimately devel...
What is the current status of trial NCT00837681?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2005-10. Estimated completion is 2016-07-08.
What conditions does trial NCT00837681 study?
This clinical trial studies the following conditions: Lung Disease.
Who is sponsoring clinical trial NCT00837681?
This trial is sponsored by Karen Wood, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00837681 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.